Indications and uses
Temporarily relieves symptoms of viral infections.
Temporarily relieves symptoms of viral infections.
Cinchona Officinalis 3X, Hydrastis Canadensis 3X, Lomatium Dissectum 3X, Nasturtium Aquaticum 3X, Nux Moschata 3X, Tabebuia Impetiginosa 3X, Uncaria Tomentosa 3X, Myrrha 3X, 6X, Gelsemium Sempervirens 6X, Germanium Sesquioxide 8X, Lachesis Mutus 8X, Glandula Suprarenalis Bovinum 8X, 10X, 12X, Thymus Gland (Suis) 8X, 10X, 24X, Nux Vomica 12X, Belladonna 12X, 30X, Epstein-Barr Virus 30X, 60X, 200X, Herpes Zoster 30X, 60X, 200X, Morbillinum 30X, 60X, 200X, Poliomyelitis 30X, 60X, 200X, Pyrogenium 30X, 60X, 200X, Hepatitis B 33X, 60X, 200X, Coxsackie B1 15C, 30C, 100C, Coxsackie B4 15C, 30C, 100C
Temporarily relieves symptoms of viral infections.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. If pregnant or breast-feeding, ask a health professional before use. Do not use if tamper evident seal is broken or missing.
10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
Demineralized Water, 25% Ethanol
In case of overdose, get medical help or contact a Poison Control Center right away.
Temporarily relieves symptoms of viral infections.
Synergy Formulas
VIROSODE
HOMEOPATHIC
2 FL OZ (60 ml)
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43772-0007-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-eb7e-f424-e053-dadaa90a57ce | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43772-0007-1 | Virosode | 60 mL in 1 BOTTLE, DROPPER | LIQUID | 60 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 43772-0007 | VIROSODE (CINCHONA OFFICINALIS, HYDRASTIS CANADENSIS, LOMATIUM DISSECTUM, NASTURTIUM AQUATICUM, NUX MOSCHATA, TABEBUIA IMPETIGINOSA) LIQUID [SYNERGY FORMULAS, INC] | 1 | Legacy NDC, 1 package rows | 20121218_156ca4f8-e1b4-4fc4-9573-34bb214c762a.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ATROPA BELLADONNA WHOLE | ACTIVE INGREDIENT | DSV74G1P2J | 1 | |
| BOS TAURUS ADRENAL GLAND | ACTIVE INGREDIENT | M2776SWB29 | 1 | |
| CAT'S CLAW | ACTIVE INGREDIENT | 9060PRM18Q | 1 | |
| CINCHONA OFFICINALIS BARK | ACTIVE INGREDIENT | S003A158SB | 1 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE INGREDIENT | 639KR60Q1Q | 1 | |
| GERMANIUM SESQUIOXIDE | ACTIVE INGREDIENT | 96WE91N25T | 1 | |
| GOLDENSEAL | ACTIVE INGREDIENT | ZW3Z11D0JV | 1 | |
| HEPATITIS B VIRUS | ACTIVE INGREDIENT | 77H9EM77P7 | 1 | |
| HUMAN COXSACKIEVIRUS B1 | ACTIVE INGREDIENT | ADL68M27WD | 1 | |
| HUMAN COXSACKIEVIRUS B4 | ACTIVE INGREDIENT | FYF75V7FDY | 1 | |
| HUMAN HERPESVIRUS 3 | ACTIVE INGREDIENT | 9885M7D6JP | 1 | |
| HUMAN HERPESVIRUS 4 | ACTIVE INGREDIENT | 2A26YW7PNX | 1 | |
| LACHESIS MUTA VENOM | ACTIVE INGREDIENT | VSW71SS07I | 1 | |
| LOMATIUM DISSECTUM ROOT | ACTIVE INGREDIENT | 5329928G5N | 1 | |
| MEASLES VIRUS | ACTIVE INGREDIENT | HT3R7C012Q | 1 | |
| MYRRH | ACTIVE INGREDIENT | JC71GJ1F3L | 1 | |
| NASTURTIUM OFFICINALE | ACTIVE INGREDIENT | YH89GMV676 | 1 | |
| NUTMEG | ACTIVE INGREDIENT | AEE24M3MQ9 | 1 | |
| POLIOVIRUS | ACTIVE INGREDIENT | FZJ641678T | 1 | |
| RANCID BEEF | ACTIVE INGREDIENT | 29SUH5R3HU | 1 | |
| STRYCHNOS NUX-VOMICA SEED | ACTIVE INGREDIENT | 269XH13919 | 1 | |
| SUS SCROFA THYMUS | ACTIVE INGREDIENT | 7B69B0BD62 | 1 | |
| TABEBUIA IMPETIGINOSA BARK | ACTIVE INGREDIENT | 6GLA1946WX | 1 | |
| ATROPA BELLADONNA WHOLE | ACTIVE MOIETY | DSV74G1P2J | 1 | |
| BOS TAURUS ADRENAL GLAND | ACTIVE MOIETY | M2776SWB29 | 1 | |
| CAT'S CLAW | ACTIVE MOIETY | 9060PRM18Q | 1 | |
| CINCHONA OFFICINALIS BARK | ACTIVE MOIETY | S003A158SB | 1 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE MOIETY | 639KR60Q1Q | 1 | |
| GERMANIUM SESQUIOXIDE | ACTIVE MOIETY | 96WE91N25T | 1 | |
| GOLDENSEAL | ACTIVE MOIETY | ZW3Z11D0JV | 1 | |
| HEPATITIS B VIRUS | ACTIVE MOIETY | 77H9EM77P7 | 1 | |
| HUMAN COXSACKIEVIRUS B1 | ACTIVE MOIETY | ADL68M27WD | 1 | |
| HUMAN COXSACKIEVIRUS B4 | ACTIVE MOIETY | FYF75V7FDY | 1 | |
| HUMAN HERPESVIRUS 3 | ACTIVE MOIETY | 9885M7D6JP | 1 | |
| HUMAN HERPESVIRUS 4 | ACTIVE MOIETY | 2A26YW7PNX | 1 | |
| LACHESIS MUTA VENOM | ACTIVE MOIETY | VSW71SS07I | 1 | |
| LOMATIUM DISSECTUM ROOT | ACTIVE MOIETY | 5329928G5N | 1 | |
| MEASLES VIRUS | ACTIVE MOIETY | HT3R7C012Q | 1 | |
| MYRRH | ACTIVE MOIETY | JC71GJ1F3L | 1 | |
| NASTURTIUM AQUATICUM | ACTIVE MOIETY | YH89GMV676 | 1 | |
| NUTMEG | ACTIVE MOIETY | AEE24M3MQ9 | 1 | |
| POLIOVIRUS | ACTIVE MOIETY | FZJ641678T | 1 | |
| RANCID BEEF | ACTIVE MOIETY | 29SUH5R3HU | 1 | |
| STRYCHNOS NUX-VOMICA SEED | ACTIVE MOIETY | 269XH13919 | 1 | |
| SUS SCROFA THYMUS | ACTIVE MOIETY | 7B69B0BD62 | 1 | |
| TABEBUIA IMPETIGINOSA BARK | ACTIVE MOIETY | 6GLA1946WX | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 43772-0007 | 43772-0007-1 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a6bdcc64-44a0-4d0f-a244-bfa178842426 | 156ca4f8-e1b4-4fc4-9573-34bb214c762a | 2012-12-04 | Warnings | a6bdcc64-44a0-4d0f-a244-bfa178842426 156ca4f8-e1b4-4fc4-9573-34bb214c762a |
Adverse event summaries are temporarily unavailable. Other product information remains available.